India to United Kingdom: Naproxen Export Trade Route
India has recorded 130 verified shipments of Naproxen exported to United Kingdom, representing a combined trade value of $3.9M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $30.0K USD. The leading Indian exporter is S KANT HEALTHCARE LIMITED, which accounts for 37% of total export value with 35 shipments worth $1.5M USD. On the buying side, TO THE ORDER is the largest importer in United Kingdom with $1.0M USD in purchases. The top 3 suppliers — S KANT HEALTHCARE LIMITED, BAFNA PHARMACEUTICALS LIMITED, FOURRTS INDIA LABORATORIES PRIVATE LIMITED — together control 62% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Naproxen corridor is one of India's established pharmaceutical export routes, with 130 shipments documented worth a combined $3.9M USD. The route is dominated by S KANT HEALTHCARE LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's naproxen manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $30.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with naproxen's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 25.9%, placing it at rank #2 among India's top naproxen export destinations globally.
On the import side, key buyers of Indian naproxen in United Kingdom include TO THE ORDER, NOUMED LIFE SCIENCES LIMITED, MILPHARM LIMITED and 10 others. TO THE ORDER is the single largest importer with 28 shipments valued at $1.0M USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portCHENNAI SEA
Market Position
- Global rank#2
- Annual growth+25.9%
- Demand growth+23.6%
- Regulatory ease86/100
Top 10 Indian Naproxen Exporters to United Kingdom
Showing top 10 of 12 Indian suppliers exporting Naproxen to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | S KANT HEALTHCARE LIMITED Avg $41.7K per shipment | 35 | $1.5M | 37.4% |
| 2 | BAFNA PHARMACEUTICALS LIMITED Avg $68.7K per shipment | 7 | $480.9K | 12.3% |
| 3 | FOURRTS INDIA LABORATORIES PRIVATE LIMITED Avg $43.3K per shipment | 11 | $476.1K | 12.2% |
| 4 | AUROBINDO PHARMA LIMITED Avg $50.4K per shipment | 8 | $403.2K | 10.3% |
| 5 | MEDREICH LIMITED Avg $18.1K per shipment | 19 | $344.8K | 8.8% |
| 6 | ARCHIMEDIS HEALTHCARE PRIVATE LIMITED Avg $9.7K per shipment | 34 | $330.1K | 8.5% |
| 7 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED Avg $112.5K per shipment | 2 | $225.0K | 5.8% |
| 8 | AUROBINDO PHARMA LTD Avg $36.8K per shipment | 5 | $184.2K | 4.7% |
| 9 | VEA IMPEX I PRIVATE LIMITED Avg $24 per shipment | 3 | $72 | 0.0% |
| 10 | DOSHI MEDICARE PRIVATE LTD Avg $12 per shipment | 3 | $36 | 0.0% |
This table shows the top 10 of 12 Indian companies exporting naproxen to United Kingdom, ranked by total trade value. The listed exporters are: S KANT HEALTHCARE LIMITED, BAFNA PHARMACEUTICALS LIMITED, FOURRTS INDIA LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LIMITED, MEDREICH LIMITED, ARCHIMEDIS HEALTHCARE PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, VEA IMPEX I PRIVATE LIMITED, DOSHI MEDICARE PRIVATE LTD. S KANT HEALTHCARE LIMITED is the dominant supplier with 35 shipments worth $1.5M USD, giving it a 37% market share. The top 3 suppliers together account for 62% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to United Kingdom Naproxen export route.
Top 10 Naproxen Importers in United Kingdom
Showing top 10 of 13 known buyers in United Kingdom receiving Naproxen shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian naproxen in United Kingdom include TO THE ORDER, NOUMED LIFE SCIENCES LIMITED, MILPHARM LIMITED, TO THE ORDER , MEDREICH PLC, among 13 total buyers. The largest importer is TO THE ORDER, accounting for $1.0M USD across 28 shipments — representing 26% of all naproxen imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER | 28 | $1.0M | 25.9% |
| 2 | NOUMED LIFE SCIENCES LIMITED | 13 | $701.2K | 18.0% |
| 3 | MILPHARM LIMITED | 9 | $464.5K | 11.9% |
| 4 | TO THE ORDER | 7 | $447.1K | 11.5% |
| 5 | MEDREICH PLC | 19 | $344.8K | 8.8% |
| 6 | CRESCENT PHARMA LIMITED | 34 | $330.1K | 8.5% |
| 7 | STRIDES PHARMA UK LIMITED | 4 | $269.9K | 6.9% |
| 8 | STRIDES PHARMA UK LTD | 3 | $211.0K | 5.4% |
| 9 | MILPHARM LIMITED ALLOGA UK | 1 | $88.1K | 2.3% |
| 10 | MILPHARM LIMITED, ALLOGA UK, | 3 | $34.8K | 0.9% |
Showing top 10 of 13 Naproxen importers in United Kingdom on this route.
Top 10 Naproxen Formulations Imported by United Kingdom
Showing top 10 of 86 product formulations shipped on the India to United Kingdom Naproxen route, ranked by trade value
United Kingdom imports a wide range of naproxen formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NAPROXEN TABLETS 500MG — accounts for $480.9K USD across 7 shipments. There are 86 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NAPROXEN TABLETS 500MG | 7 | $480.9K | 12.3% |
| 2 | HARMLESS MEDICINE- NAPROXEN 500 MG TABLETS UNIT: 2X14 | 9 | $355.6K | 9.1% |
| 3 | HARMLESS MEDICINE- NAPROXEN 500 MG TABLETS Unit: 2x14 | 3 | $332.8K | 8.5% |
| 4 | NAPROXEN 500MG TABLETS (NAPROXEN TABLETSBP 500 MG) 2X14'S | 4 | $237.3K | 6.1% |
| 5 | HARMLESS MEDICINE NAPROXEN 500 MG TABLETS UNIT 2x14 Tab | 3 | $214.0K | 5.5% |
| 6 | HARMLESS MEDICINES NAPROXEN 500 MG TABLETS UNITS: 2X14 X 189100 CARTONS | 1 | $187.3K | 4.8% |
| 7 | NAPROXEN 500 MG TABLETS UNIT:2 X 14 | 1 | $166.3K | 4.3% |
| 8 | NAPROXEN 500MG TABLETS(156851X2X14S) | 1 | $124.1K | 3.2% |
| 9 | NAPROXEN 500MG TABLETS 78869X2 X14PKS | 2 | $120.5K | 3.1% |
| 10 | NAPROXEN 500MG TABLETS(130479X2X14S) | 1 | $100.9K | 2.6% |
Showing top 10 of 86 Naproxen formulations imported by United Kingdom on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHENNAI SEA handles the highest volume with 20 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's naproxen exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. S KANT HEALTHCARE LIMITED with 35 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — S KANT HEALTHCARE LIMITED, BAFNA PHARMACEUTICALS LIMITED, FOURRTS INDIA LABORATORIES PRIVATE LIMITED — together account for 62% of total trade value on this route. The average shipment value of $30.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine- naproxen 500 mg tablets unit: 2x14 and harmless medicine- naproxen 500 mg tablets unit: 2x14, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER is the largest importer with 28 shipments worth $1.0M USD — representing 26% of all naproxen imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.9M
- Avg. Shipment
- $30.0K
- Suppliers
- 12
- Buyers
- 13
- Transit (Sea)
- ~21 days
- Annual Growth
- +25.9%
Reverse Direction
United Kingdom → India — Naproxen (Import)Other Naproxen Routes
Unlock the Full India to United Kingdom Naproxen Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 130 shipments on this route.
Frequently Asked Questions — India to United Kingdom Naproxen Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Naproxen to United Kingdom?
The leading Indian exporters of Naproxen to United Kingdom are S KANT HEALTHCARE LIMITED, BAFNA PHARMACEUTICALS LIMITED, FOURRTS INDIA LABORATORIES PRIVATE LIMITED. S KANT HEALTHCARE LIMITED holds the largest market share at approximately 37% of total trade value on this route.
Q What is the total value of Naproxen exports from India to United Kingdom?
India exports Naproxen to United Kingdom worth approximately $3.9M USD across 130 recorded shipments. The average value per shipment is $30.0K USD.
Q Which ports does India use to ship Naproxen to United Kingdom?
The most active port of origin is CHENNAI SEA with 20 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United Kingdom for Naproxen?
The average transit time for Naproxen shipments from India to United Kingdom is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United Kingdom Naproxen trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.9% with demand growth tracking at 23.6%. The route is ranked #2 among India's top Naproxen export destinations globally.
Q How many suppliers are active on the India to United Kingdom Naproxen route?
There are currently 12 active Indian suppliers exporting Naproxen to United Kingdom. The market is moderately concentrated with S KANT HEALTHCARE LIMITED accounting for 37% of total shipment value.
Q Who are the main importers of Naproxen from India in United Kingdom?
The leading importers of Indian Naproxen in United Kingdom include TO THE ORDER, NOUMED LIFE SCIENCES LIMITED, MILPHARM LIMITED, TO THE ORDER , MEDREICH PLC. TO THE ORDER is the largest buyer with 28 shipments worth $1.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Naproxen.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 13 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 130 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
130 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists